Page 149 - Read Online
P. 149

Park et al. J Cancer Metastasis Treat 2019;5:17  I  http://dx.doi.org/10.20517/2394-4722.2018.84                             Page 9 of 12

               A

















               B                                     C




















               Figure 4. ICAM-1 is important for attachment and cytotoxicity of T cells to breast cancer. A: Labelled T cells attached to MDA-MB-231LN
               cells monolayer. AF1q significantly reduced the number of attached T cells to the monolayer. When AF1q expression was suppressed,
               the number of attached T cells was increased. The Bar graph represents the % adhesion cells of total cells; B: ICAM-1 blocking antibody
               significantly reduced the number of attached T cells to the monolayer; C: a 72 h cytotoxicity assay was performed in 24 well plates where
               co-cultured at 10:1 or 20:1 E:T ratio with MDA-MB-231LN cells


               DISCUSSION
               We have here identified ICAM-1 which reciprocally regulated by AF1q was associated with metastasis
               of cancer cells. Although elevated AF1q expression is associated with poor clinical outcomes in various
                          [4-6]
               malignancies , the function of AF1q is not yet fully understood. Our findings further explain why high
               AF1q expression is associated with poor clinical outcomes. However, greater mechanistic understanding of
               how AF1q is involved in promoting cancer metastasis is necessary before these laboratory investigations can
               be translated into clinical interventions. Thus, it is very important to continue to investigate the underlying
               biological functions of AF1q and its association with breast cancer metastasis.


               We observed that nuclear factor-kappa B (NF-κB) activity was attenuated in response to AF1q expression
               in breast cancer cells (data not shown). NF-κB translocated to the nuclers binds to the proximal NF-
               κB consensus sequence of the ICAM-1 promoter and binding of NF-κB to the proximal binding site of
                                                                [17]
               the ICAM-1 promoter induces transcriptional activity . Published reports show that Wnt/β-catenin
               negatively regulates NF-κB activity through a β-catenin-NF-κB interaction in colon and breast cancer
               cells [18,19] . β-catenin can physically complex with NF-κB, resulting in a reduction of NF-κB DNA binding,
                                                            [20]
               transactivation activity, and target gene expression . Activated β-catenin is associated with repressed
                                                [20]
               NF-κB activity in human cancer cells . Interestingly, the interaction between them is only indirect, as
               these two proteins do not bind to each other without a helper protein. Structurally, AF1q has highly acidic
               peptide regions highly conserved between species that fulfill the criteria for an acidic blob, a typical feature
               for cofactors. We also noted an internal peptide repeat within the sequence of 90 amino acids of human
                                                                                              [2]
               AF1q, which is located at both ends of the peptide, indicative of similar binding interfaces . Previously,
   144   145   146   147   148   149   150   151   152   153   154